Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer

Recruiting

Who can join

Ages 18 and older · All sexes

Full eligibility criteria

Inclusion Criteria:

1. Newly diagnosed patients with solid tumor cancer diagnosis or recurrence of the disease.
2. Patients must have the ability to understand and willingness to provide verbal consent.
3. Participants must speak English, Spanish, Chinese, or Vietnamese.

Exclusion Criteria:

1. Inability to consent to the study
2. Plans to change oncologist within 12 months
3. Employed by the practice site
4. Patients who anticipate moving from the area within 12 months

About the study

This cluster-randomized comparative effectiveness trial compares a technology-based supportive cancer care (SCC) approach with a redesigned team-based supportive cancer care (SCC) approach.

What is being tested

Receive technology-based supportive cancer care (other)
Receive redesigned team-based supportive cancer care (behavioral)

Sponsor: Stanford University · Participants: 2,996 · Started: Jun 24, 2022

Contact the study team

Manali I Patel, MD MPH MS · Phone: 6507234000

Official record on ClinicalTrials.gov — NCT05297734

Locations in the U.S.

Alabama	University of Alabama at Birmingham, Birmingham University of South Alabama, Mobile
California	Beckman Research Institute of City of Hope, Duarte VA Medical Center, Fresno, Fresno Santa Clara Valley Medical Center, Fruitdale St Jude Heritage Medical Group, Fullerton Oncology Institute for Hope and Innovation, Los Angeles Kaiser Foundation Research Institute, San Francisco University of San Francisco, San Francisco Zuckerberg San Francisco General, San Francisco
Hawaii	Spark M. Matsunaga VA Medical Center, Honolulu
Utah	George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City

Conditions

From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.